ClinicalTrials.Veeva

Menu

Novel Robotic Surgical System for Minimally Invasive Surgery (K2robo)

The Chinese University of Hong Kong logo

The Chinese University of Hong Kong

Status

Enrolling

Conditions

Robotic Surgery

Treatments

Device: K2 Robotic Surgical System

Study type

Interventional

Funder types

Other

Identifiers

NCT05151835
CREC 2021.472

Details and patient eligibility

About

This is a prospective single center cohort study on effect of a novel robotic surgical system for performance of minimally invasive surgery in multiple specialties. The targeted procedures include Urological, upper and lower GI robotic surgeries and the expected sample size will be 20 patients. The clinical outcomes for assessment include background demographics, operative time, perioperative complications as well as completion rate of procedure, hospital stay and recovery.

Full description

This is a prospective single center cohort study on effect of a novel robotic surgical system for performance of minimally invasive surgery in multiple specialties. The targeted procedures include Urological, upper and lower GI robotic surgeries and the expected sample size will be 20 patients. The procedures will be standardized according to previously reported. The diseases for robotic surgical treatment will include prostate carcinoma, colorectal carcinoma, as well as esophageal hiatal diseases and gastric carcinoma. The clinical outcomes for assessment include background demographics, operative time, perioperative complications as well as completion rate of procedure, hospital stay and recovery.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Body mass index <35 kg/m2
  2. Suitable for the listed minimally invasive surgical procedures for treatment of respective diseases
  3. Willingness to participate as demonstrated by giving informed consent

Exclusion criteria

  1. Contraindication to general anesthesia
  2. Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
  3. Untreated active infection
  4. Noncorrectable coagulopathy
  5. Presence of another malignancy or distant metastasis
  6. Emergency surgery
  7. Vulnerable population (e.g. mentally disabled, pregnancy)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Robotic Surgery
Experimental group
Description:
Prospective single arm study to investigate effect of a novel robotic surgical system on safety, efficacy and outcomes for performance of minimally invasive surgery across urology, upper and lower GI surgery.
Treatment:
Device: K2 Robotic Surgical System

Trial contacts and locations

1

Loading...

Central trial contact

Man Yee YUNG, RN; Philip WY Chiu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems